Valeritas Holdings, Inc.: Chapter 11 case summary
ElevenFlo · · Sources changed since
Valeritas Holdings’ Chapter 11 reached liquidation-plan effectiveness, as reported in the effective-date notice Dkt. 436 filed June 30, 2020. Following authorization of an asset sale, the next phase was implementation of the liquidation plan confirmed by the court’s confirmation order Dkt. 410 filed June 8, 2020.
Valeritas Holdings, Inc.’s February 9, 2020 Chapter 11 proceeding reached effectiveness of a confirmed liquidation plan, as reported in the effective-date notice Dkt. 436 filed June 30, 2020. The court’s confirmation order Dkt. 410, filed June 8, 2020, established the liquidation plan as the framework for the next phase of estate administration.
Valeritas developed and marketed V-Go, a wearable insulin-delivery device for patients with type 2 diabetes. According to the first-day declaration Dkt. 4, a December 2019 manufacturing yield problem disrupted supply, caused a $3.5 million inventory write-off and prompted two potential buyers to withdraw. Chinese New Year and the coronavirus outbreak compounded the manufacturing disruption, while reduced inventory and employee-retention concerns threatened business continuity. These pressures led the company to pursue a Chapter 11 sale.
The same declaration Dkt. 4 described a stalking-horse agreement with Zealand Pharma A/S for $23 million in cash, plus assumption of up to $1.5 million in cure costs, with retention of substantially all employees as a condition. Those were the proposed transaction terms. The court authorized postpetition financing and collateral use through the final DIP order Dkt. 181 filed March 13, 2020, and authorized the sale of substantially all debtor assets through the sale order Dkt. 232 filed March 20, 2020.
The debtors, unsecured creditors’ committee and prepetition lenders then jointly proposed the liquidation plan Dkt. 283 filed April 7, 2020. Confirmation and the subsequent effectiveness notice moved the proceeding from sale authorization and plan negotiation into implementation of the confirmed liquidation plan.
Sources
- Dkt. 4First Day DeclarationFiled Feb 9, 2020Feb 9, 2020
- Dkt. 181Final Order (I) Authorizing the Debtors to Obtain Postpetition Financing, (II) Authorizing the Debtors to Use Collateral, (III) Granting Liens and Providing Superpriority Administrative Expense Status, (IV) Granting Adequate Protection, (V) Modifying the Automatic Stay, and (VI) Granting Related ReliefFiled Mar 13, 2020Mar 13, 2020
- Dkt. 232Order (I) Authorizing the Sale of Substantially All of the Debtors' Assets Free and Clear of Liens, Claims, Encumbrances, and Interests, (II) Approving the Agreement, (III) Authorizing the Assumption and Assignment of Certain Executory Contracts and Unexpired Leases, and (IV) Granting Related ReliefFiled Mar 20, 2020Mar 20, 2020
- Dkt. 283Combined Disclosure Statement and Joint Chapter 11 Plan of Liquidation Proposed by Valeritas Holdings, Inc. and its Affiliated Debtors, the Official Committee of Unsecured Creditors, and the Prepetition Lenders (Filed by Valeritas Holdings, Inc.)Filed Apr 7, 2020Apr 7, 2020
- Dkt. 410Findings of Fact, Conclusions of Law, and Revised Order (I) Approving Combined Disclosure Statement and Joint Chapter 11 Plan of Liquidation as Containing Adequate Information on a Final Basis and (II) Confirming Combined Disclosure Statement and Joint Chapter 11 Plan of LiquidationFiled Jun 8, 2020Jun 8, 2020
- Dkt. 436Notice of Occurrence of Effective Date Under Third Amended Combined Disclosure Statement and Plan (related document(s)[283], [309], [410]) Filed by Valeritas Holdings, Inc.. (Martin, R.)Filed Jun 30, 2020Jun 30, 2020